Biomarker and cognitive associates of resistance to neocortical tau pathology in a pooled cohort
Alzheimer's & Dementia · 2025-12 · 21 (S3)
DOI: 10.1002/alz70857_106460 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 25.12.2025. Verfasst von Colin Birkenbihl und 22 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Prior evidence suggests that neocortical tau in those with higher β‐amyloid (Aβ) may be the main driver of Alzheimer's disease (AD)‐related neurodegeneration leading to insidious cognitive decline and ultimately a diagnosis of AD dementia. Resistance to the ‘spread’ of neocortical tau pathology from localized medial temporal (MTL) regions can be defined as individuals having lower neocortical tau than expected given their individual characteristics, such as demographics and Aβ burden. We examined associations between resistance to neocortical tau pathology and various markers of AD pathology, cognitive performance, and brain reserve.
Method
We calculated tau resistance using our published inverse learning method (Figure 1B), which estimates the deviation away from a model trained on an expectation sample (278 Aβ‐PET+ older adults with high neocortical tau‐PET (PVC_SUVR composite :inferior temporal/inferior parietal/fusiform/middle temporal) burden based on Gaussian Mixture Modeling;Figure 2A). We ran a series of linear regression models on the remaining 1,374 older adults pooled from the Harvard Aging Brain Study (HABS), ADNI, and A4/LEARN (Demographics in Figure 1A). We examined associations between tau resistance and 1) MTL tau‐PET (PVC_SUVR composite ; entorhinal/amygdala/parahippocampal), 2) measures of brain reserve (hippocampal volume and entorhinal cortical thickness), 3) neocortical Aβ‐PET burden (Centiloids), 4) an interaction between MTL tau and Aβ‐PET, and 5) cognitive performance (PACC). All models adjusted for age, sex, education, cohort, and APOE ε4.
Results
Lower MTL tau, lower Aβ, and younger age were significantly associated with higher neocortical tau resistance (β MTL =‐0.22(0.06), p < 0.001, Figure 2B; β Aβ =‐0.13(0.03), p
Zitieren
APA
Birkenbihl, C., Klinger, H. M., Properzi, M. J., Cuppels, M., Brown, J. A., Coughlan, G. T., Seto, M., Li, A., Chhatwal, J. P., Hanseeuw, B. J., Farrell, M. E., Jacobs, H. I., Carrigan, M., Langford, O., Price, J. C., Schultz, A. P., Rentz, D. M., Amariglio, R. E., Johnson, K. A., …, & Buckley, R. F. (2025). Biomarker and cognitive associates of resistance to neocortical tau pathology in a pooled cohort. Alzheimer's & Dementia, 21(S3). https://doi.org/10.1002/alz70857_106460
Vancouver
Birkenbihl C, Klinger HM, Properzi MJ, Cuppels M, Brown JA, Coughlan GT, et al. Biomarker and cognitive associates of resistance to neocortical tau pathology in a pooled cohort. Alzheimer's & Dementia. 2025;21(S3). doi:10.1002/alz70857_106460
BibTeX
@article{Birkenbihl2025,
author = {Birkenbihl, Colin and Klinger, Hannah M and Properzi, Michael J. and Cuppels, Madison and Brown, Jane A and Coughlan, Gillian T and Seto, Mabel and Li, Annie and Chhatwal, Jasmeer P. and Hanseeuw, Bernard J and Farrell, Michelle E. and Jacobs, Heidi I.L. and Carrigan, Maria and Langford, Oliver and Price, Julie C and Schultz, Aaron P. and Rentz, Dorene M. and Amariglio, Rebecca E. and Johnson, Keith A. and Sperling, Reisa A. and Donohue, Michael C. and Hohman, Timothy J. and Buckley, Rachel F.},
title = {Biomarker and cognitive associates of resistance to neocortical tau pathology in a pooled cohort},
journal = {Alzheimer's & Dementia},
year = {2025},
volume = {21},
number = {S3},
doi = {10.1002/alz70857_106460}
}
EUVIMED